02:37 PM EDT, 03/24/2026 (MT Newswires) -- Concentrix ( CNXC ) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.

Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.

ImmunityBio ( IBRX ) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing "misleading" promotional materials for its bladder cancer drug Anktiva.

Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.

Lenz Therapeutics ( LENZ ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.

Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.

Price: 25.12, Change: -7.92, Percent Change: -23.97